Artivion, Inc. (AORT) — Fair Value Analysis

Base-case fair value (P50): $21.74 · Current price: $23.79 · Verdict: Fairly Valued

The Verdict on AORT

ARTIVION INC (AORT) is currently assessed as Fairly Valued by our Monte Carlo simulations. The stock’s current trading price of $23.79 is slightly above its median fair value (P50) of $21.74, representing a -8.6% difference. This suggests that while there is a slight premium, it falls within the range considered balanced, preventing a verdict of significantly overvalued or undervalued at this time.

How AORT stacks up against Healthcare

AORT operates within the Healthcare sector and holds an "average" quality tier in terms of its operational and financial health compared to its peers. This average standing supports the Fairly Valued verdict, indicating that the company's fundamentals do not warrant a substantial premium or discount against the sector, despite the $23.79 current price exceeding the $21.74 median fair value by -8.6%. The current valuation reflects a company with typical sector strengths and weaknesses.

What this means for investors

For investors considering ARTIVION INC, the Fairly Valued status implies the stock is appropriately priced relative to its fundamental outlook as captured by our Monte Carlo models. The current price of $23.79 versus the median fair value of $21.74 suggests that the market has largely priced in available information. While there is a -8.6% difference, it's not substantial enough to categorize AORT as either a deep value play or significantly overextended. To understand the full range of potential outcomes, including both downside scenarios and the probability of upside, investors can leverage FairCurve. Sign up for FairCurve to see the full bear/bull distribution and track AORT's fair value as new fundamentals are released.